Bruker Corporation to Present at Investor Conferences
February 22 2023 - 4:15PM
Business Wire
Bruker Corporation (Nasdaq: BRKR) announced today that Gerald
Herman, Executive Vice President & CFO will present on behalf
of the Company at the following investor conferences:
Citi 2023 Healthcare Services, Medtech, Tools & HCIT
Conference in New York City Thursday, March 2, 2023, at 9:30
a.m. Eastern Time
Cowen 43rd Annual Health Care Conference in Boston, MA
Monday, March 6, 2023, at 2:10 p.m. Eastern Time
Live audiovisual webcasts of the presentations will be available
on the Investor Relations section of the Company's website at
https://ir.bruker.com. Replays of the presentations will be posted
in the “Events & Presentations” section of the Bruker
Corporation Investor Relations website after the events and will be
available for 90 days following the presentations.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high performance scientific instruments and high
value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular, and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity, and customer success in
life-science molecular and cell biology research, in applied and
pharma applications, in microscopy and nanoanalysis, as well as in
industrial research, semiconductor metrology and cleantech
applications. Bruker offers differentiated, high-value life science
and diagnostics systems and solutions in preclinical imaging,
clinical phenomics research, proteomics and multiomics, spatial and
single-cell biology, functional structural and condensate biology,
as well as in clinical microbiology and molecular diagnostics. For
more information, please visit: www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230222005988/en/
Justin Ward Sr. Director, Investor Relations & Corporate
Development Bruker Corporation T: +1 (978) 663–3660, ext. 1479 E:
Investor.Relations@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024